Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
New to Comunitee?

or Sign Up with Email


>> ABLYNX Latest News

NOV 21, 2014 - Yahoo! News

A Must Read - Share

Ablynx says blood disorder drug estimates conservative

By Philip Blenkinsop BRUSSELS (Reuters) - Belgian biotech company Ablynx believes its sales estimate for its drug for the rare blood disease TTP is conservative, after tests showed it had potential to treat more than just acute cases. Ablynx recently raised its estimate for peak annual sales for the TTP candidate drug caplacizumab to 300-400 million euros ($373-497 million), from ...

Tags: Ablynx says blood disorder drug estimates conservative,  Ablynx Latest News